Related Experiment Videos
[Malignant central nervous system tumors are susceptible to specific antibodies]
O P Blizniukov1, L D Kozmin, V E Oliushin
1St. Petersburg Institute of Nuclear Physics, Russian Academy of Sciences, Gatchina.
Voprosy Onkologii
|April 25, 2001
The binding of circulating specific IgG to glioblastoma cells from brain tumor biopsies was shown using fluorescence conjugate Protein A-FITC and Western blotting. Blood-brain barrier permeability for antitumor antibodies in vivo in glioblastoma patients is suggested.
The binding of circulating specific IgG to glioblastoma cells from brain tumor biopsies was shown using fluorescence conjugate Protein A-FITC and Western blotting. Blood-brain barrier permeability for antitumor antibodies in vivo in glioblastoma patients is suggested.